还没做过化疗，EGFR是野生型的病友一定要去做ALK的检测

jzjqian 发表于 2012-7-25 15:45

- o7 L9 }6 O6 B5 @                               
登录/注册后可看大图

2 E9 V' p  l5 k7 \' _7 M请教，像我这样的，手术22个月了，还能去原手术医院拿到病理作EGFR检查么？

* H9 I& W3 l3 [8 ^2 h可以，但要有针对性，

请问，肺鳞癌，只做过一次化疗，骨髓抑制严重，后吃特罗凯4个月基本无效，可以参加实验组吗？

不可以了,要没做过任何治疗的,包括化疗和靶向药

Concomitant EGFR mutation and EML4-ALK gene fusion in non-small cell lung cancer.  Print this page  
3 ?( M5 C4 S$ \

Sub-category:
Molecular Targets
- }# q4 Z6 o5 H9 N
2 t# T+ r: B! D# Y
Category:
Tumor Biology


& n+ N7 T( R7 I+ i0 t: b  s, hMeeting:
% @7 P& |" G  M! ^- v2011 ASCO Annual Meeting
+ o( O8 E( b# }; N/ S% _

7 X: V3 w& M/ g; |% L5 d5 KSession Type and Session Title:
Poster Discussion Session, Tumor Biology
3 ~/ z+ D% c, u- w1 v! `
% Q- X7 h/ m" g! @, z0 q+ r
Abstract No:
1 i4 m  K! @+ l10517
5 I3 J3 d) ~( d+ }

Citation:
6 B' R4 b. {9 |9 y9 q$ nJ Clin Oncol 29: 2011 (suppl; abstr 10517)
, [3 C0 K3 f. d& s
4 T% l  x) Z0 j! b/ c: o+ _; L7 z3 \) M
0 O" M$ `& _" x) o  QAuthor(s):
J. Yang, X. Zhang, J. Su, H. Chen, H. Tian, Y. Huang, C. Xu, Y. L. Wu; Guangdong Lung Cancer Institute, Guangdong General Hospital & Guangdong Academy of Medical Sciences, Guangzhou, China; Guangdong Lung Cancer Institute, Medical Research Center of Guangdong General Hospital, Guangzhou, China; Guangdong Lung Cancer Institute, Guangzhou, China; Guangdong Lung Cancer Institute, Guangdong General Hospital & Guangdong Academy of Medical Sciences, Guangzhou, China



Abstracts that were granted an exception in accordance with ASCO's Conflict of Interest Policy are designated with a caret symbol (^) here and in the printed Proceedings.

Abstract Disclosures

Abstract:
1 T* H5 x' ~% r! O
! Q8 |' J, _. p1 |1 W/ M
Background: The fusion of the anaplastic lymphoma kinase (ALK) with the echinoderm microtubule-associated protein-like 4 (EML4) and epidermal growth factor receptor (EGFR) mutations are considered mutually exclusive. Advanced non-small cell lung cancer (NSCLC) patients with EML4-ALK did not benefit from EGFR tyrosine kinase inhibitors (TKIs). Methods: Multiplex reverse transcriptase-polymerase chain reaction (RT-PCR) followed by sequencing was performed for EML4-ALK fusion status detection. EGFR and KRAS mutations were determined by direct DNA sequencing. Positive results of EML4-ALK fusion were also confirmed by RACE-coupled PCR sequencing. Results: From April 2010 to January 2011, 412 patients (398 with NSCLC; 14 with SCLC) were tested for mutation status of EGFR, KRAS and EML4-ALK respectively. Frequency of EML4-ALK fusion was 10.6% (42/398) in NSCLC patients. No patients with SCLC were found to have positive EML4-ALK fusion. Frequency of concomitant EGFR and EML4-ALK gene mutations was 1.0% (4/398) in NSCLC patients, and their variants of EML4-ALK gene mutations were Variant 1 (3 patients) and Variant 6 (1 patient); being never smokers, all of them were diagnosed with advanced (3 with stage †W and 1 with stage IIIB) adenocarcinoma harbouring wild type KRAS. Two female stage †W patients with double gene mutations (1 with L858R and Variant 1; 1 with exon19 deletion and Variant 6) received first-line gefitinib which is one kind of EGFR TKIs and achieved partial response. Conclusions: Though being rare events, NSCLC patients harbouring concomitant EGFR mutation and EML4-ALK gene fusion are sensitive to first-line EGFR TKIs. Whether they could also benefit from ALK inhibition after failure to EGFR TKIs warranted further investigation.
5 v- X8 ~0 ^& l% A% W

+ ?$ u4 P& A4 m7 m: x5 e

由吴一龙教授牵头的A80810029临床试验上周启动，初诊未治疗的晚期肺腺癌患者检测到ALK阳性，可参加一线crizotinib 对比力比泰+卡铂的临床研究，药物全部免费，即使分配到力比泰组，疾病进展之后可免费获得crizotinib.

没有手术，只化疗过，现吃靶向药，未突变，alk未测，有机会入组吗？

boeun 发表于 2012-11-18 16:37

2 r9 r2 ?0 q& H* i0 o0 R                               
登录/注册后可看大图

没有手术，只化疗过，现吃靶向药，未突变，alk未测，有机会入组吗？

$ w" ]7 M( C" J/ w, I化疗过的没机会了

平安！ 发表于 2012-7-20 11:20

                               
登录/注册后可看大图

易瑞沙、特罗凯有效的病人基本上可以断定ALK（-）。极其罕见EGFR、ALK同时突变的。
% X3 M7 x2 E' D- }* L! e1 t9 @ALK一个指标医院要900多 ...

平安，真的没有希望吗？我弟弟虽然特罗凯有效，但是ＥＧＦＲ是野生型，不是突变啊。有没有必要去检测ＡＬＫ呢？

/ h* t3 z1 O7 n现在病情进展，快没招儿了。

好像想加入挺困难的

小地方没条件做啊